Bill Text — Mar 18, 2015
This bill’s text is now available.
Jun 19, 2014
113th Congress, 2013–2015
This bill was introduced on June 19, 2014, in a previous session of Congress, but was not enacted.
Representative for Ohio's 15th congressional district
Read Text »
Last Updated: Jun 19, 2014
Length: 2 pages
To require the Food and Drug Administration to expedite review of pharmaceuticals that are approved for marketing in the European Union.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Referred to Committee
Last Action: Mar 18, 2015
The “H.R.” in “H.R. 4918” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
Search for similar bills.
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 4918 — 113th Congress: Speeding Access to Already Approved Pharmaceuticals Act of 2014. Retrieved from https://www.govtrack.us/congress/bills/113/hr4918
“H.R. 4918 — 113th Congress: Speeding Access to Already Approved Pharmaceuticals Act of 2014.” www.GovTrack.us. 2014. June 30, 2015 <https://www.govtrack.us/congress/bills/113/hr4918>
|title=H.R. 4918 (113th)
|accessdate=June 30, 2015
|author=113th Congress (2014)
|date=June 19, 2014
|quote=Speeding Access to Already Approved Pharmaceuticals Act of 2014